I might be missing the point, but there really hasn't been that much changed since December 29th 2023. The company actually stated 13th of May 2024 that H2 2024 was the target for ethics submission via the May Investor Presentation. You want clarity on the points raised, but I want clarity on why people aren't reading the material properly. If the end goal is a patient dosed in 2024, then it doesn't make sense to get upset now when the only thing that has changed since December 2023 is the company trying to more accurately predict the key events listed.
This is the most recent update as of the 26th September 2024.
RAC Price at posting:
$1.69 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)